ClinicalTrials.Veeva

Menu

Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences

University Hospital Basel logo

University Hospital Basel

Status

Enrolling

Conditions

Multiple Sclerosis (MS)

Treatments

Other: patient questionnaire
Procedure: SC MRI

Study type

Interventional

Funder types

Other

Identifiers

NCT04819737
2021-00269 ko21Parmar;

Details and patient eligibility

About

This study is to evaluate the sensitivity and intra-/inter-observer agreement of the averaged magnetization inversion recovery acquisitions (AMIRA) in spinal cord (SC) Multiple sclerosis (MS) lesion detection and to evaluate the additional clinical value of this sequence in clinical settings.

Full description

An averaged magnetization inversion recovery acquisitions (AMIRA) sequence was proposed for SC MRI. This MR-sequence delivers excellent contrast between the SC gray and white matter as well as between the SC and cerebrospinal fluid (CSF) in clinically feasible-acquisition times. Moreover, the high quality and in-plane resolution of AMIRA images allows for segmentation of the SC gray and white matter with high accuracy and reproducibility. This study is to evaluate the sensitivity and intra-/inter-observer agreement of the averaged magnetization inversion recovery acquisitions (AMIRA) in spinal cord (SC) Multiple sclerosis (MS) lesion detection and to evaluate the additional clinical value of this sequence in clinical settings.

Enrollment

10 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of multiple sclerosis according to established international criteria
  • Steroid free period: > 4 weeks
  • Participation in the Swiss MS Cohort (SMSC) study

Exclusion criteria

  • . History of severe (other) neurological, internal or psychiatric disease with SC affection

  • MRI-related exclusion criteria (questionnaire):

    1. Paramagnetic and/or superparamagnetic foreign objects in the body (especially when located close to the SC)
    2. Pacemaker
    3. Claustrophobia
    4. Pregnancy, lactation
    5. Known hypersensitivity to gadolinium-based contrast media

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

Spinal Cord MRI
Experimental group
Treatment:
Procedure: SC MRI
Other: patient questionnaire

Trial contacts and locations

1

Loading...

Central trial contact

Charidimos Tsagkas, Dr. med.; Katrin Parmar, PD Dr. med.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems